XIST and Alzheimer disease: A novel study investigating the impact of lncRNA XIST in AD through the epigenetic modulation of Aβ-degrading enzymes’ expression demonstrated that AD individuals exhibit elevated lncRNA XIST levels in conjunction with noticeable signs of neuroinflammation.